Nuvation Bio

$5.71 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Nuvation Bio

Nuvation Bio Inc. operates as a bio-pharmaceutical company. The Company focuses on developing oncology medicines that will improve patient lives by addressing drug resistance. Nuvation Bio serves patients worldwide.

Stock Analysis

last close $5.61
1-mo return -30.7%
3-mo return -40.2%
avg daily vol. 693.08T
52-week high 15.23
52-week low 5.3
market cap. $1.3B
forward pe -
annual div. -
roe -22.5%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 67.4%
baraka

Subscribe now for daily local and international financial news

Subscribe